Apr 25, 2026
Thermo Fisher Raises Outlook As Clario Deal Deepens AI Trial Capabilities
Thermo Fisher Scientific has finalized its acquisition of Clario, enhancing its capabilities in clinical trial technology and AI-driven research.This strategic move has led Thermo Fisher to revise its revenue and earnings per share forecasts upward, reflecting anticipated contributions from Clario. The integration of Clario's advanced tools is expected to significantly benefit biopharma clients by improving trial efficiency and data quality, particularly as the industry increasingly focuses on t